← All companies
Dyne Therapeutics, Inc.
DYN - CIK 0001818794
Market cap$2.92 B
Rank#1827
SEC filings710
The table below shows Dyne Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $398.33M | $281.41M | $210.76M | $142.76M | $121.31M | $45.20M |
| SG&A | $69.85M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.